In Search of the Correct Diagnosis of Beta-lactam Allergy: From the Validation of a Risk Stratification Tool to Accurate Endotyping

Testing a clinical decision tool (BL-Predictor)

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Drug Allergy Chemically-Induced Disorders Drug Hypersensitivity Drug-Related Side Effects and Adverse Reactions

Age range

14 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

signed informed consnet

Exclusion criteria

Use of immunomodulators, antihistamines and corticosteroids

Treatment and study plan

BL-Predicter

Diagnostic Test

To Clinically validate the BL-Predictor toll by a randomised conytrolled ttrial

Primary outcomes

The main goal of this project is to test a cliniacl decision toll to stratify BL allergic pataients in low and mediaum- anf high-risk

Time frame: April 2029- june 2027

And to carry out a deep dissection of the cellular mechanisms of B cells sensitization and basophil and neutrophil activation in BL-IRs to develop accurate in vitro diagnostic test

Study contacts

Contact information is provided by the study sponsor or research team.

Marina Labella Alvarez MLB Bonilla Toyos

CONTACT

[email protected]

+34951032058

Sponsors and collaborators

Lead sponsor

Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud

Other

Registry information

Acronym: Allergy

Important dates

Study start: 2025
Primary completion: 2027
Study completion: 2027
First posted: Jun 8, 2025
Registry last updated: Jun 8, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting